Medicenna Therapeutics Corp. Cash Flows From Used In Investing Activities
Medicenna Therapeutics Corp. (MDNAF) reported Cash Flows From Used In Investing Activities of CAD 0 for the 3-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2023-06-27
- Medicenna Therapeutics Corp. cash flows from used in investing activities for the quarter ending 2023-03-31 was 0.00 CAD, a 100.00% decline year-over-year.
- Medicenna Therapeutics Corp. cash flows from used in investing activities for the quarter ending 2022-03-31 was 10.05M CAD, a 100.48% increase year-over-year.
- Medicenna Therapeutics Corp. cash flows from used in investing activities for the quarter ending 2021-03-31 was 5.01M CAD.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|
| 2023-03-31 | 0.00 CAD 20-F · filed 2023-06-27 | |
| 2022-03-31 | 10.05M CAD 20-F · filed 2023-06-27 | 10.05M CAD 20-F · filed 2022-06-22 |
| 2021-03-31 | 5.01M CAD 20-F · filed 2023-06-27 | 5.01M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | -15.00M CAD 20-F · filed 2022-06-22 |